BML Investment Partners L.P. 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-09 6:05 pm Sale | 2025-12-09 | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 0 0.000% | -2,149,880 (Position Closed) | Filing |
| 2025-12-05 6:18 pm Sale | 2025-12-04 | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 2,149,880 9.700% | -1,099,446 (-33.84%) | Filing |
| 2025-11-10 12:32 pm Unchanged | 2025-11-10 | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 3,249,326 15.600% | 0 (Unchanged) | Filing |
| 2025-05-20 08:27 am Purchase | 2025-05-19 | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 3,249,326 15.600% | 367,009 (+12.73%) | Filing |
| 2025-05-06 09:15 am Purchase | 2025-03-31 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 2,882,317 13.800% | 508,913 (+21.44%) | Filing |
| 2025-02-13 3:25 pm Purchase | 2024-12-31 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 2,373,404 11.400% | 167,058 (+7.57%) | Filing |
| 2024-07-22 4:24 pm Purchase | 2024-07-17 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 2,206,346 10.600% | 1,065,346 (+93.37%) | Filing |
| 2024-04-29 4:10 pm Purchase | 2024-04-18 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 1,141,000 5.500% | 655,575 (+135.05%) | Filing |
| 2024-02-07 11:36 am Sale | 2023-12-31 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 485,425 2.300% | -244,593 (-33.51%) | Filing |
| 2023-02-08 4:44 pm Purchase | 2023-02-08 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 730,018 7.300% | 212,468 (+41.05%) | Filing |
| 2022-05-10 12:40 pm Purchase | 2022-05-04 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 517,550 5.200% | 517,550 (New Position) | Filing |